Navigation Links
ProMetic provides business update - Over $35 million worth of business secured in January
Date:2/6/2008

e,

representing annual recurring revenue of $5 M. The initial five-

year supply agreement is in final stage of negotiation with

commercial quantities of resin supply commencing as soon as mid-

2008, following regulatory approval of the product.

- The Food and Drug Administration ("FDA") has granted approval to

Zymogenetics, Inc. for the commercial sale of Recothrom(R) a

recombinant thrombin product which is manufactured using a synthetic-

ligand affinity adsorbent supplied by ProMetic. This is one of ten

licenced products that have now been approved for sale by the FDA

and/or the European Medicines Agency ("EMEA") which uses ProMetic's

purification technology as part of their manufacture or function.

- Improved sensitivity by 80-fold of existing diagnostic devices was

achieved by pre-treating the samples with PRDT's enhanced concentration

technology. The results showed an added level of sensitivity to the BSE

detection process, thereby reducing the risk of "false outcomes" with

existing tests. This could allow for the detection of infectious prions

at an earlier phase in the development of the disease, thus improving

the safety of the food industry for the countries testing for BSE.

A more comprehensive update for PBI-1402 will be provided shortly as the Company is pursuing its clinical development and as partnership discussions are accelerating.

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. (http://www.prometic.com) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand(TM) technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is als
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
2. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
3. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
4. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
5. Amarin Provides Business Update and Announces Implementation of Reverse Stock Split
6. YM BioSciences provides update on AeroLEF(TM) clinical development program
7. ViroPharma Provides 2008 Outlook
8. Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis
9. Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
10. Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
11. Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... TALLAHASSEE, Fla. Exciting new work by a Florida ... molecular system that can take your temperature, emit white ... , And, the molecule looks like a butterfly. , ... and Biomedical Engineering in the FAMU-FSU College of Engineering, ... ago, but has continued to discover that his creation ...
(Date:8/28/2014)... PrimeSource Building Products, Inc., a ... SoundConnect to support their communication needs with ... web conferencing platform GlobalMeet powered by SoundConnect. The ... SoundConnect delivers award winning “results driven” business ... will be utilizing GlobalMeet powered by SoundConnect ...
(Date:8/27/2014)... Green & Grow Inc. (GGI) has raised ... secured Otter Capital as a significant new partner. Otter ... GGI’s Agriplier™ technology, building on recent compelling field trial ... first meeting, we have been impressed with Otter Capital’s ... Alan Sobba, President and CEO of GGI. “We look ...
(Date:8/27/2014)... DENVER , Aug. 27, 2014   MSC ... and patient safety, today announced the appointment of ... With 28 years of experience preparing companies ... in 2013 as Executive Vice President of Corporate Development ... healthcare performance improvement business , as well as corporate ...
Breaking Biology Technology:Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2PrimeSource Chooses SoundConnect as Collaboration Provider 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3MSC names Mary Beth Loesch President and CEO 2
... Removal of unincorporated dye-terminators is required, ... instrumentation. CleanSEQ has proven an efficient and, ... ABI 3700 and 3730xl sequencers. Samples run on the, ... air before machine injection which can have deleterious, ...
... , Agencourts ... method for purifying nucleic acid products generated in common enzymatic , ... cRNA. The kit is formatted for microarray , ... automated formats. RNAClean eliminates the need for vacuum filtration ...
... , ... of thousands of genes in a single experiment. One limitation of ... RNA may be required for each array hybridization , ... working with limited samples, such as small biopsies, mRNA-poor ...
Cached Biology Technology:CleanSEQ on the ABI 3100 2CleanSEQ on the ABI 3100 3CleanSEQ on the ABI 3100 4RNAClean - RNA & cDNA in vitro Reaction Purification 2RNArticles: RNA Amplification Used to Develop a New In Vitro HCMV Assay 2RNArticles: RNA Amplification Used to Develop a New In Vitro HCMV Assay 3RNArticles: RNA Amplification Used to Develop a New In Vitro HCMV Assay 4
(Date:8/29/2014)... researchers explored the type and number of connections in ... plays on robustness in a study published in ... found that the assortativity signature contributes to a network,s ... that varying the out-out assortativity of TFN models has ... the other three types of assortativity," said Dov A. ...
(Date:8/29/2014)... the prolific bloomer Emiliania huxleyi , can grow ... finding contradicts the common view that E. huxleyi ... supplies of thiamine in the ocean to survive. , ... ocean," says CIFAR Senior Fellow Alexandra Worden , ... CIFAR fellows John Archibald (Dalhousie University), ...
(Date:8/29/2014)... USA - The rise of the Tibetan plateau -- ... -- is important for both its profound effect on ... study published in GSA Bulletin , Katharine Huntington ... isotope thermometry -- using modern and fossil snail shells ... in southwestern Tibet. , Views range widely on ...
Breaking Biology News(10 mins):Assortativity signatures of transcription factor networks contribute to robustness 2Not all phytoplankton in the ocean need to take their vitamins 2Not all phytoplankton in the ocean need to take their vitamins 3Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7
... Barbara have found strong evidence that niche differences are critical ... issue of the journal Nature. "Ecologists have ... environment are key to explaining the large number of species ... niches have never been field tested," said first author Jonathan ...
... Monday, August 17th at 1:30PM in Hensill Hall 113, attendees ... in San Francisco will get to learn about the latest ... in the field. The symposium is called Good Science ... Public. (Online link: http://www.sou.edu/aaaspd/2009SANFRANCISCO/Symposia09.html#15 ). As science has ...
... for schizophrenia have lower cancer rates than other people ... help treat some major cancers. A preliminary finding ... Journal of Cancer reports that the anti-psychotic drug, ... in-vitro laboratory experiments. Several epidemiological studies have ...
Cached Biology News:Scientists demonstrate importance of niche differences in biodiversity 2Science communication to take the stage at annual AAAS meeting in San Francisco 2Anti-psychotic drugs could help fight cancer 2
... The Helios gene gun system, 100-120 ... of biomaterials into cells. This handheld device ... DNA-, RNA-, and other biomaterial-coated gold microcarriers ... plastic cartridge directly into target cells. This ...
... polyclonal antibody raised against a ... Immunogen: ZFHX4 (NP_078997, ... partial recombinant protein with GST ... Number: NM_024721 ...
... antibody raised against a partial ... Immunogen: K6HF (NP_004684, 141 ... recombinant protein with GST tag. ... NM_004693 ...
... The binding specificity and signaling of the ... to be modified by alternative splicing--which has ... SpliceArrays you can perform a classical expression ... the different alternatively spliced forms of the ...
Biology Products: